Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Street

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Cancer Discovery|June 19, 2025
Catalytic inhibition of KAT6/KAT7 enhances the efficacy and overcomes primary and acquired resistance to Menin inhibitors in MLL leukaemiaShellaina J V Gordon, Florian Perner, Laura MacPherson, et al.
Nature|December 13, 2019
HBO1 is required for the maintenance of leukaemia stem cellsLaura MacPherson, Juliana Anokye, Miriam M Yeung, et al.
Nature|August 3, 2018
Inhibitors of histone acetyltransferases KAT6A/B induce senescence and arrest tumour growthJonathan B Baell, David J Leaver, Stefan J Hermans, et al.
Cell Chemical Biology|August 9, 2023
Discovery of a highly potent, selective, orally bioavailable inhibitor of KAT6A/B histone acetyltransferases with efficacy against KAT6A-high ER+ breast cancerShikhar Sharma, Chi-Yeh Chung, Sean Uryu, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Cancer Discovery|June 19, 2025
Catalytic inhibition of KAT6/KAT7 enhances the efficacy and overcomes primary and acquired resistance to Menin inhibitors in MLL leukaemiaShellaina J V Gordon, Florian Perner, Laura MacPherson, et al.
Nature|December 13, 2019
HBO1 is required for the maintenance of leukaemia stem cellsLaura MacPherson, Juliana Anokye, Miriam M Yeung, et al.
Nature|August 3, 2018
Inhibitors of histone acetyltransferases KAT6A/B induce senescence and arrest tumour growthJonathan B Baell, David J Leaver, Stefan J Hermans, et al.
Cell Chemical Biology|August 9, 2023
Discovery of a highly potent, selective, orally bioavailable inhibitor of KAT6A/B histone acetyltransferases with efficacy against KAT6A-high ER+ breast cancerShikhar Sharma, Chi-Yeh Chung, Sean Uryu, et al.
Pageof 6